Mahboobeh Mahdavinia is a Rheumatology/Immunology physician. OpenAlex indexes 252 publications with 3,718 citations (h-index 32).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6410 Fannin St Ste 720
Houston, TX 770305205
Telephone
713-486-0340Provider last certified this registry record 9 Jan 2025.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year202516 payments$10,356openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20258 payments
- Blueprint Medicines CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
61.2%Interleukin-4 Receptor alpha Antagonist61.2%Dupixent Syringe100%Part D<11 patientsRespiratory
38.8%Anti-IgE20%Xolair100%Part D<11 patientsCorticosteroid18.8%Fluticasone Propionate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2023–2023 per NIH RePORTER. The latest:
- Cognitive Impairment in Chronic Rhinosinusitis
University of Texas Hlth Sci Ctr Houston
FY2023$4,352R03TR004005
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2)
The Journal of Allergy and Clinical Immunology In Practice
2024 - Gut microbiome is associated with asthma and race in children with food allergy
Journal of Allergy and Clinical Immunology
2023 - African American Children Are More Likely to Be Allergic to Shellfish and Finfish: Findings from FORWARD, a Multisite Cohort Study
The Journal of Allergy and Clinical Immunology In Practice
2021 - Association of Air Pollutant Exposure and Sinonasal Histopathology Findings in Chronic Rhinosinusitis
American Journal of Rhinology and Allergy
2021 - Defining the Allergic Endotype of Chronic Rhinosinusitis by Structured Histopathology and Clinical Variables
The Journal of Allergy and Clinical Immunology In Practice
2021
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”